Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety Study of an Immunomodulating Microparticle to Treat Progressive Multiple Sclerosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01191996
Recruitment Status : Completed
First Posted : August 31, 2010
Last Update Posted : December 7, 2012
Sponsor:
Collaborators:
Primorus Clinical Trials
National Multiple Sclerosis Society
Information provided by (Responsible Party):
Innate Immunotherapeutics